JUSTIFICATION OF THE USE OF SURVEILLANCE IN THE MANAGEMENT OF STAGE-1 GERM-CELL TUMORS OF THE TESTIS

被引：42

作者：

OLIVER, RTD ^{[1
]}

HOPESTONE, HF ^{[1
]}

BLANDY, JP ^{[1
]}

机构：

[1] LONDON HOSP,COLL MED,DEPT UROL,LONDON E1 1BB,ENGLAND

来源：

BRITISH JOURNAL OF UROLOGY | 1983年 / 55卷 / 06期

关键词：

D O I：

10.1111/j.1464-410X.1983.tb03421.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：760 / 763

页数：4

共 20 条

[1]

BLANDY JP, 1975, UROLOGY, P1203

[2]

Blandy JP., 1970, TUMOURS TESTICLE

[3]

BODEN G, 1951, LANCET, V2, P1195

[4]

Chevassu M., 1906, THESIS PARIS

[5]

DONOHUE JP, 1978, CANCER-AM CANCER SOC, V42, P2903, DOI 10.1002/1097-0142(197812)42:6<2903::AID-CNCR2820420653>3.0.CO

[6]

2-K

[7]

EINHORN LH, 1980, CANCER, V46, P1339, DOI 10.1002/1097-0142(19800915)46:6<1339::AID-CNCR2820460607>3.0.CO

[8]

2-J

[9]

Hope-Stone H F, 1963, Br Med J, V1, P984

[10] CHEMOTHERAPY OF METASTATIC TESTICULAR-TUMORS [J].

OLIVER, RTD ;

ROHATINER, AA ;

WRIGLEY, PFM ;

MALPAS, JS .

BRITISH JOURNAL OF UROLOGY, 1980, 52 (01) :34-37